Six-month-old cancer startup makes $166M Nasdaq debut By: Boston Business Journal via Business Journals July 29, 2021 at 13:05 PM EDT Almost exactly six months after emerging from stealth, cancer startup Nuvalent is hitting the public markets in a $166 million IPO. Read More >>
